Saltar al contenido
Merck

70967

Reactivo de transfección GeneJuice®

Non-lipid based chemical transfection reagent optimized for maximum transfection efficiency, ease-of-use, and minimal cytotoxicity on a wide variety of mammalian cells.

Sinónimos:

Reactivo de transfección, Transfección GeneJuice

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño



About This Item

NACRES:
NA.54
UNSPSC Code:
41106502

Nombre del producto

Reactivo de transfección GeneJuice®, Non-lipid based chemical transfection reagent optimized for maximum transfection efficiency, ease-of-use, and minimal cytotoxicity on a wide variety of mammalian cells.

form

liquid

manufacturer/tradename

Novagen®

storage condition

OK to freeze

technique(s)

transfection: suitable

shipped in

wet ice

storage temp.

2-8°C

Quality Level

Disclaimer

Toxicidad: Inflamable (J)

Features and Benefits

  • Transferencia de ADN muy eficiente para transfecciones estables y transitorias
  • Compatibilidad con medios que contienen suero y medios que no contienen suero
  • Protocolo sencillo, sin necesidad de cambiar medios
  • Ideal para transfección de gran rendimiento en formato de placa multipocillo
  • Ideal para la producción de retrovirus para la transducción de células T
  • Funciona para muchos tipos de células con una optimización mínima
  • Proporciona una eficiencia de transfección mayor y una citotoxicidad menor que los reactivos de otros proveedores
  • El tamaño de 1 ml proporciona suficiente reactivo como para realizar hasta 500 transfecciones en placas convencionales de 35 mm

General description

«Utilizo GeneJuice porque es fácil de utilizar, tiene baja toxicidad y una amplia variedad de células diana»
Stuart Rulten. Research Fellow. Universidad de Sussex

«Desde que trabajamos con GeneJuice, hemos ahorrado mucho tiempo y dinero»
Dr. Andrea Kress, Instituto de biología clínica y molecular, Erlangen, Alemania

«Me parece que Genejuice funciona para muchos tipos de células con una optimización mínima»
Caitriona Marie Lyons. Estudiante de doctorado University College Cork, Irlanda

La transfección es el proceso mediante el cual se introducen ácidos nucleicos en células de mamífero. El reactivo de transfección GeneJuice es una formulación patentada optimizada para una máxima eficiencia de la transfección, facilidad de uso y mínima citotoxicidad para las células de mamífero. Mientras que muchos de los reactivos de transfección disponibles se basan en la formulación lipídica catiónica, el reactivo de transfección GeneJuice está compuesto por una proteína celular no tóxica y una pequeña cantidad de una nueva poliamina. El reactivo de transfección GeneJuice permite una transferencia muy eficiente de ADN en transfecciones estables y transitorias de células eucariotas y es ideal para transfecciones de gran rendimiento en un formato de placa multipocillo. Su composición exclusiva es compatible con medios que contienen suero y medios que no lo contienen, lo que hace que sea innecesario el cambio de medios durante los experimentos de transfección. Genejuice es una alternativa superior a una amplia variedad de otras técnicas, como la coprecipitación de fosfato de calcio, la electroporación, la microinyección, la administración de partículas biolísticas, la lipofección y la formación de complejos con DEAE-dextrano. El tamaño de 1 ml proporciona suficiente reactivo para realizar hasta 500 transfecciones en placas convencionales de 35 mm.


Líneas celulares transfectadas con GeneJuice® Reactivo de transfección
Líneas celulares:células primarias:
10T1/2

293T

3T3 NIH

3T3 Swiss

3T3-L1

A204

A431

A549

alfa TC1-6

AR 42J

As4.1

AtT-20

B50

BC-1

BC-2

BC3

BCBL

BHK-21

C3H/10T1/2

C6

C2C12
Caco-2

Caki-1

Calpan-1

Calu-1

Calu-6

CCL-131

CFPAC-1

Chang Liver

CHO

CHO-7

CHO-IR

CHO-K1

COS-1

COS-7

CS-1

CV-1

Daudi

DDTI MF-2

DT40

ECV304

EL4
ES-E14TG2a

EVSCC17M

H9c2

HCT-116

HEK293

HeLa

HeLa B

HeLa T4

Hep 3B2.1-7

HepG2

Hepa 1-6

Ht-29

HTB-37

HTB-45

Huh-7

HUVEC

IC21

IEC-6

JEG-3

Jurkat

KB
L57-3-11

L-6

L-929

MA-10

McA-RH7777

MCF-7

MCF-10-2A

MDCK

Melanocito

MG-63

Neuro 2A

Neuroblastoma

NRK

NT2/D1

OV-1063

OVCAR3

P4

P19

PC12

PA317

PAM212
PS-1

R2C

RAW 264.7

RBL-2H3

RMP-41

SAOS-2

SC-1

Schneider line2

SK-N-MC

SK-N-SH

SKOV3

STO

SW-480

SW-837

T3M4

TM4

U937

UCD

Vero

Células de músculo liso aórtico

Astrocitos

Angioblastos

Condrocitos

Células cromafines

Células epiteliales:

mamarias

prostáticas

traqueales

Fibroblastos

Queratinocitos

Reactivo de transfección química no lipídico optimizado para una máxima eficiencia de la transfección y facilidad de uso, y una mínima citotoxicidad en una amplia variedad de células de mamífero.

Legal Information

GeneJuice® es una marca registrada de EMD Chemicals Inc.
GENEJUICE is a registered trademark of Merck KGaA, Darmstadt, Germany
NOVAGEN is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Debido a la naturaleza de los materiales peligrosos de este envío, podrían aplicarse gastos de envío a su pedido. Ciertos tamaños pueden estar exentos de los gastos de envío añadidos a los materiales peligrosos. Consulte a su oficina local de ventas si desea más información relativa a dichos gastos.

Preparation Note

Si desea ver el protocolo, pulse aquí

pictograms

FlameExclamation mark

signalword

Danger

hcodes

Hazard Classifications

Eye Irrit. 2 - Flam. Liq. 2

Clase de almacenamiento

3 - Flammable liquids

wgk

WGK 1

flash_point_f

67.1 °F - Information taken from reference works and the literature.

flash_point_c

19.5 °C - Information taken from reference works and the literature.


Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

  1. Why do I need to perform optimization? How should I go about doing it?

    Each cell type behaves differently, by carrying out an optimization, the best transfection condition for your particular cell type can be determined. In other words, you can avoid putting too much transfection reagent on your cells, which may cause unnecessary toxicity issue and waste of precious transfection reagent. Optimization is suggested for every new combination of cell type and plasmid. The most important parameters are cell density and ratio of transfection reagent to DNA. Start with the volume of the selected transfection reagent (1x) and plasmid amount (1x) as recommended in the User Protocol. If those conditions do not yield the desired results, an optimization experiment can be performed. In a 24-well plate, plate the same amount of cells in each well. Set up a gradient across the plate and add the appropriate volume of transfection reagent (0.5x, 1x, 1.5x, 2x, 2.5x and 3x). Set up a gradient down the plate and add the appropriate amount of plasmid (0.5x, 1x, 1.5x and 2x). With a reporter gene in the plasmid, the optimal condition can be easily determined.

  2. What is the size limit for plasmid DNA?

    Large plasmids in the range of 12-15 kb can be transfected. We have cloned and expressed inserts encoding large proteins (including β-gal) without difficulty in mammalian cell lines.

  3. Is the quality of DNA important for good transfection?

    Yes, it is essential that the DNA to be transfected is of high quality and free of endotoxins. Plasmid DNA preparations should include an endotoxin removal step.

  4. How long should I leave the transfection reagent on the cells? Do I need to change medium at any time after transfection?

    Since our nucleic acid transfection reagents are compatible with serum-containing media, medium change after transfection is not necessary. The majority of cell types can be incubated with the transfection mix for 24-72h without any media change, and then harvested for the desired downstream application. If media change is necessary due to the toxicity of the protein being expressed, the transfection mixture can be removed after 2-8 h of incubation and replaced with complete growth medium.

  5. Can I use the product in the presence of serum?

    Yes. Our nucleic acid transfection reagents are effective for transfecting cells in media with or without serum. While cells can be incubated in media containing serum, it is absolutely critical that serum is NOT present during formation of the transfection reagent/DNA complex. For most applications, we recommend adding the transfection reagent/DNA complex (formed in serum-free media) to cells grown in complete growth media. For certain cell lines and experimental conditions, serum starvation of cells might be required. Since serum provides growth factors and nutrients, transfection efficiencies achieved with growth in serum containing media are typically better than those in serum-free media.

  6. Can the DNA transfection reagents be used for co-transfecting plasmids?

    Yes. Multiple plasmids can be transfected into the cell at the same time. The key is to maintain the optimal ratio of total DNA (all plasmids). See the User Protocols for more information on the ratio of reagent to DNA.

  7. Will antibiotics interfere with transfection?

    We do not recommend including antibiotics during the formation of the transfection reagent/DNA complex. Increased cell permeability during transfection causes high antibiotic influx, resulting in cell death. Some antibiotics (such as kanamycin) are cationic and can therefore interfere with transfection. Antibiotics such as penicillin and streptomycin can be present in the complete growth media (with serum) which is used to grow the cells. If you are generating stable transfectants, add selection antibiotics (e.g., G 418 or hygromycin) 48-72h after transfection.

  8. How do I scale my transfection protocol when working with different culture volumes?

    For most standard culture formats, guidelines are provided in the User Protocol. If you are using different culture volumes, vary the amounts of DNA, transfection reagent, cells, and culture media in proportion to the relative surface area while keeping the transfection reagent: DNA ratio constant.

Sharon Eisenberg et al.
Molecular and cellular biology, 31(19), 3938-3952 (2011-08-03)
The trafficking, membrane localization, and lipid raft association of Ras proteins, which are crucial oncogenic mediators, dictate their isoform-specific biological responses. Accordingly, their spatiotemporal dynamics are tightly regulated. While extensively studied for H- and K-Ras, such information on N-Ras, an
Linda Brunotte et al.
The Journal of biological chemistry, 286(44), 38748-38756 (2011-09-16)
The nucleoprotein (NP) of Lassa virus (LASV) strain AV was expressed in a recombinant baculovirus system. The crystal structure of full-length NP was solved at a resolution of 2.45 Å. The overall fold corresponds to that of NP of LASV
Natasha C Lucki et al.
The Journal of biological chemistry, 286(22), 19399-19409 (2011-04-16)
Sphingolipid metabolites, such as ceramide (Cer), sphingosine (SPH), and sphingosine 1-phosphate (S1P), contribute to multiple aspects of carcinogenesis including cell proliferation, migration, angiogenesis, and tumor resistance. The cellular balance between Cer and S1P levels, for example, is an important determinant
Mark G Frost et al.
Bioscience reports, 40(6) (2020-05-19)
Fanconi Anemia (FA) is a rare genetic disorder characterized by developmental defects, bone marrow failure and high predisposition to cancer. The FA DNA repair pathway is required in humans to coordinate repair of DNA interstrand cross-links. The central event in
Ju Huang et al.
Autophagy, 7(1), 17-26 (2010-10-29)
Autophagy mediates the degradation of cytoplasmic components in eukaryotic cells and plays a key role in immunity. The mechanism of autophagosome formation is not clear. Here we examined two potential membrane sources for antibacterial autophagy: the ER and mitochondria. DFCP1

Contenido relacionado

Successful delivery of nucleic acids and protein in eukaryotic cells requires a transfection protocol that maximizes transfection ef؀ciency, minimizes cytotoxicity, and results in the desired level of gene expression or silencing. EMD Millipore recognizes that there is not a one-size-؀ts-all solution to your transfection needs. We provide the breadth of transfection reagents necessary to give you the freedom to design the perfect experiment.

Ver todo

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico